Senior insider sale
CEO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$5.81M
150.48K shares
What this filing means
PIMSTONE SIMON N. plans to sell 150.48K shares of XENON PHARMACEUTICALS INC. valued at approximately $5.81M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2023ACC: 0000950170-23-025799
DirectorOfficer· CEO
Since Sep 2019
150.48K
Shares to sell
$5.81M
Approx. market value
31.71K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Options
Net Exercise
6/1/2023
31.71KTotal acquired31.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2023 | Exercise of Options Net Exercise | 31.71K | — |
| Total | 31.71K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
12K
Market value
$462.4K
5/31/2023
—Completed
Units to sell
50.53K
Market value
$1.96M
5/31/2023
—Completed
Units to sell
37.01K
Market value
$1.45M
5/30/2023
—Completed
Units to sell
19.23K
Market value
$711.2K
3/7/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
31.71K
Market value
$1.23M
6/1/2023
Total
Units
150.48K
Value
$5.81M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/31/2023 | 12K | $462.4K | — | Completed |
5/31/2023 | 50.53K | $1.96M | — | Completed |
5/30/2023 | 37.01K | $1.45M | — | Completed |
3/7/2023 | 19.23K | $711.2K | — | Completed |
| Planned — Approximate Date | ||||
6/1/2023 | 31.71K | $1.23M | NASDAQ | Planned |
| Total | 150.48K | $5.81M | ||